دانلود کتاب کاهش آسیب روانگردان

Interest in the therapeutic and transformative potential of classic psychedelics such as lysergic acid diethylamide (LSD), psilocybin, and 5-methoxy-dimethyltryptamine (5-MeO-DMT) has resumed. These substances have been used as medicines by Indigenous cultures for centuries, and recent clinical trials show promising results for the treatment of certain mental health conditions, including depression, anxiety, and substance use disorders. In light of what has been labeled “the crisis of psychopharmacology,” psychedelics offer renewed hope, representing novel treatment approaches in which psychopharmacology and psychotherapeutic techniques are inextricably intertwined. While other psychopharmacological agents must be administered on a daily basis, most therapeutic approaches involving psychedelics are limited to one or a few applications. Moreover, unlike other psychoactive agents associated with rewarding and habit-forming properties, psychedelics may facilitate complex cognitions and emotions such as spiritual experiences, gratitude, humility, empathy, and pro-social behaviors that can extend beyond the substance’s acute effects in the body. In contrast to traditional psychopharmacology, psychedelics have therefore been proposed as treatments that may offer healing beyond the mere reduction of symptoms.